New science in molecular and genetic testing for breast, colon, and prostate cancer, as well as leukemia, will be among the special features at the College of American Pathologists’ annual scientific and education meeting, CAP ’14: The Pathologists’ Meeting, September 7–10, at the Hyatt Regency in Chicago.
Gene N Herbek, MD, FCAP
“More accurate diagnoses and precise treatments through molecular diagnostics offer new hope for the millions of patients battling cancer each year,” says CAP President Gene N. Herbek, MD, FCAP. “As the doctors who diagnose disease and guide treatment, pathologists want to keep current on the new diagnostic procedures that can enhance patient care. CAP ’14 brings together the leading experts in laboratory medicine to share the latest information to benefit patients.”
World-renowned experts in pathology and laboratory medicine will examine the clinical and economic impact of genomic-based testing, as well as share insights on the pathologist’s role in coordinated care models and appropriate test selection to reduce medical costs and unnecessary testing. Highlighted scientific topics and educational courses include:
- Special Scientific Plenary Session: “Molecular Medicine—Can We Afford It?” led by national thought leaders:
Debra G.B. Leonard, MD, PhD, FCAP, chair of pathology at the University of Vermont
David O. Meltzer, MD, PhD, a health economist at the University of Chicago
Adam C. Berger, PhD, director of the Institute of Medicine’s roundtable on translating genomic-based research for health
- Beyond the microscope, emerging technologies and new ways to guide clinical decision-making
- The use of clinical informatics in an era of meaningful use
A complete list of CAP ’14 “hot topics” is available via the organization’s website. With a membership of more than 18,000 board-certified pathologists, the College of American Pathologists is the leading organization serving patients, pathologists, and the public by fostering and advocating excellence in the practice of pathology and laboratory medicine worldwide. For more information, visit CAP.
